Foundation time-series models have recently shown potential for forecasting complex temporal signals, but their behavior in patient-specific continuous glucose monitoring (CGM) forecasting remains insufficiently understood, particularly when only glucose history is available. This study provides a patient-level benchmark of foundation models for 30 min ahead glucose prediction in adults with type 1 diabetes mellitus (T1DM) under a strictly univariate CGM-only setting. Using the HUPA–UCM dataset from 25 individuals, we evaluated TimeGPT, Chronos, and Sundial against representative statistical, machine learning, and deep learning forecasters, including ARIMA, ETS, gradient-boosting models, recurrent networks, and neural forecasting architectures. Models were assessed using a local walk-forward validation strategy over the final 24 h of CGM data for each patient. Foundation models achieved the strongest global performance, with Sundial obtaining the lowest overall MAE (), while TimeGPT and Chronos remained among the most competitive approaches. However, patient-level analyses showed that this advantage was not uniform: ARIMA remained highly competitive in selected individuals, and no single model consistently dominated across the cohort. These findings suggest that foundation time-series models are promising tools for short-horizon CGM forecasting, but their use should be framed within patient-specific model selection rather than as universal replacements for classical forecasting methods.